Cleveland Clinic-Taussig Cancer Center ( Site 2203) — Cleveland, Ohio

Cleveland Clinic-Taussig Cancer Center ( Site 2203) is a clinical research site located in Cleveland, Ohio, United States 44195.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Cleveland Clinic-Taussig Cancer Center ( Site 2203) has participated in 1 clinical trials.

Therapeutic areas: Hodgkin Lymphoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cleveland Clinic-Taussig Cancer Center ( Site 2203)?

Cleveland Clinic-Taussig Cancer Center ( Site 2203) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cleveland Clinic-Taussig Cancer Center ( Site 2203) conducted?

Cleveland Clinic-Taussig Cancer Center ( Site 2203) has 1 clinical trials on record. Their work covers Hodgkin Lymphoma.

Is Cleveland Clinic-Taussig Cancer Center ( Site 2203) accredited by Crixeo Health?

Cleveland Clinic-Taussig Cancer Center ( Site 2203) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cleveland Clinic-Taussig Cancer Center ( Site 2203)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.